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Abstract − The two aims of this study were: 1) to bring 
together Rasch measurement methods (RMMs) with sub-
stantive clinically-grounded hypotheses to develop measures 
of health-related quality of life and patient satisfaction for 
reconstructive and cosmetic breast surgery; and 2) develop 
an accessible scoring program to provide automated clini-
cally interpretable scores, based on calibrated item locations. 
We constructed a new patient reported outcome (PRO) in-
strument (BREAST-Q ©) from patient interviews (n=48), 
focus groups (n=18), and expert opinion. It was then field-
tested in samples of breast surgery patients (n=1950 & 
n=817). Item generation led to three separate modules for 
different types of breast surgery, each with a pre- and post-
operative version: 1) augmentation; 2) reconstruction; and 3) 
reduction. RMMs supported the summing of items to form a 
total score for all subscales, in each module. Based on these 
analyses the Q-Score © scoring algorithm program was 
developed, tested and finalised. The BREAST-Q © is an 
advance on the way PROs are currently measured and can 
provide essential information about the impact and effec-
tiveness of breast surgery from the patients’ perspective. 
The Q-Score © program enables the BREAST-Q © to be 
widely used and interpreted correctly, underpinned by an 
equivalent frame of reference across different clinical set-
tings. 
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1.  INTRODUCTION 
Traditionally the discussion of outcomes in plastic 
surgery has centred on the provider’s perspective, 
focusing on measuring complications and considering 
photographic analyses. However, such data alone are 
no longer sufficient to support the progress being 
made in the field [1]. As the specialty of plastic sur-
gery continues to develop, more sophisticated ways of 
examining outcomes are required. Recently, expres-
sions such as “quality of life” and the “patient’s voice” 
have caught the attention of consumers, the public, 
health care payers, and policymakers [2, 3].  
Breast surgery is typical of the wider picture in 
plastic surgery. As such, rapidly advancing tech-
niques, increasing involvement of patients in their 
own surgical decision-making and concern over esca-
lating healthcare expenditures has resulted in growing 
scrutiny of surgical outcomes and cost [4-6]. More 
recently, this emphasis on evidence-based practice [7] 
has been coupled with a new focus on key indicators 
such as health-related quality of life and patient satis-
faction (HR-QL) [1]. Thus, there is now more demand 
for high quality specially designed questionnaires, 
known as patient-reported outcome  (PRO) instru-
ments, in cosmetic and reconstructive breast surgery 
research, trials and practice [8]. 
Despite the growing demand, our systematic re-
view found that only seven of 223 PRO instruments 
used in breast surgery studies had psychometric evi-
dence to support their use in a breast surgery popula-
tion [8]. Furthermore, only one instrument (developed 
for breast reduction patients) was reported to have 
psychometric properties in line with current proposed 
psychometric criteria [9]. However, this measure was 
limited in the range of outcomes it captured (i.e., did 
not address key areas such as aesthetics and body 
image) [8].  
Therefore, we identified a need for a new clinically 
meaningful, scientifically sound PRO instrument that 
measures the perceptions of reconstructive and cos-
metic breast surgery patients. Such an instrument 
could facilitate comparisons of different surgical tech-
niques from a patient perspective, and provide a refer-
ence point for comparisons between studies and surgi-
cal populations. Therefore, the central objective of this 
project was to develop pre- and post-surgical measures 
of HR-QL and patient satisfaction for reconstructive 
and cosmetic breast surgery. As part of the study de-
sign process, we drew up a check list of three key 
areas to address, which we expand upon below. These 
ensured the development of an appropriate, practical, 
clinically meaningful and scientifically rigorous new 
instrument. As such, the new instrument should: 
 
• appropriately capture the patient perspective 
and include clinically relevant and meaning-
ful domains 
• be underpinned by an appropriate measure-
ment model 
• be applicable for research and clinical set-
tings and be easy to administer and score 
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1.1. The patient perspective 
Guidelines for developing PRO instruments [9], 
including the current widely quoted US Food and 
Drug Administration’s (FDA) scientific requirements 
for PROs in clinical trials [2, 10], highlight the impor-
tance of establishing validity. In particular, the FDA 
emphasises appropriate conceptual frameworks and 
definitions as being fundamental. These are best 
achieved using detailed qualitative assessments which 
should include: evaluating the extent to which a 
scale’s items represent the construct to be measured; 
establishing the most appropriate item phrasing, struc-
turing and context; and cognitive debriefing to ensure 
consistency in meaning.  
In developing the new PRO instrument for cos-
metic and reconstructive breast surgery, we selected a 
range of qualitative methods including in-depth pa-
tient and clinician interviews, literature review, panel 
meetings, and cognitive debriefing [11, 12]. 
However in addition to these methods, we also 
strove to develop explicit descriptions of each sub-
scale, in order to maximise their utility as clinically 
interpretable tools. As such, the new PRO instrument 
was developed ‘bottom-up’ (from a construct defini-
tion), rather than ‘top-down’ (from a method of group-
ing items) to ensure that substantive clinical grounded 
hypotheses determined subscale content. This in-
volved several rounds of iterative qualitative enquiry 
utilising the methods described above to establish 
clinical validity. This approach is keeping with Rasch 
paradigm [13, 14] (which we revisit below), and pro-
vides the optimal foundations to fully understand the 
measurement performance of each of the new sub-
scales [15, 16].  
Over the last 25 years one group outside of health 
measurement has developed the understanding of 
construct definitions and construct theories to an ad-
vanced level [17-19]. This group, led by Jack Stenner, 
has argued for a change in focus of assessing validity 
from studying the people to the items [18] and in par-
ticular the relationships between item characteristics 
and item scores. This forms the building blocks of the 
theory of the construct. Stenner et al use the following 
analogy to describe a construct theory: “The story we 
tell about what it means to move up and down the 
scale for a variable of interest (e.g. temperature, read-
ing, ability, short term memory). Why is it, for exam-
ple, that items are ordered as they are on the item 
map? [This] story evolves as knowledge increases 
regarding the construct” 
(p308) [17]. 
It is extremely rare to find PRO instruments asso-
ciated with explicit construct theories in the health 
measurement literature. This may be due to historical 
reasons [20]. However, as a key part of our goal for 
this project was to appropriately capture the patient 
perspective and include clinically relevant and mean-
ingful domains, we looked ahead to what could be 
achieved by following Stenner, et al’s example, and 
therefore, focussed on developing as advanced as 
possible construct definitions (and thus begin to build 
construct theories) for each subscale. 
 
1.2. An appropriate measurement model 
In health measurement research, there are three 
main psychometric approaches broadly based on three 
types of measurement model: Classical Test Theory, 
Rasch Measurement Theory, and Item Response The-
ory [20]. Below, we briefly examine each of these 
approaches in order to present a justification for the 
approach that we chose. 
 
1.2.1 Classical Test Theory 
The dominant psychometric paradigm in the de-
velopment and testing of PRO instruments, which is 
used in the current guidelines for developing PRO 
instruments, such as FDA document described above 
[2, 10] is classical (or traditional) test theory (CTT). 
Charles Spearman laid down the foundations of CTT 
in 1904 [21], in which he introduced the following 
equation:  
 ܱ ൌ ܶ ൅ ܧ 
(1) 
 
where the observed score (O) is the person’s mani-
fest score on a scale. The true score (T) is the person’s 
‘real’ score. This is unobservable (a theoretical value) 
because of the associated measurement error – the 
error score (E). CTT then postulates that the observed 
score (O) is the sum of the True score (T) and the 
error score (E). Thus, it assumes that the relationship 
between the true score and the error score is additive 
rather than anything else (e.g. multiplicative).  
Over the next 50 years, the role of CTT analyses 
grew with the accumulation of statistical evidence to 
establish the scientific robustness of measures (e.g. 
Kuder-Richardson’s coefficients for internal inconsis-
tency, Cronbach’s alpha, correlations between repli-
cated measurements) [22].  
Importantly, CTT is grounded in the definition of 
measurement as proposed by Stanley Smith Stevens 
(ie ‘the assignment of numerals to objects or events 
according to some rule’) [23]. This definition differs 
in important respects from the more classical defini-
tion of measurement adopted throughout the physical 
sciences, which is that measurement is the numerical 
estimation and expression of the magnitude of one 
quantity relative to another [24]. CTT is based upon 
analyses of raw scores that are used to test the as-
sumptions underlying a given measurement model; 
that the items can be summed (without weighting or 
standardization) to produce a score. The key tradi-
tional psychometric properties commonly associated 
with CTT are: data quality, scaling assumptions, tar-
geting, reliability, validity, and responsiveness. We 
and others describe these assessments in more detail 
elsewhere [2, 25]. 
CTT was the cornerstone for psychometric evalua-
tions during the last century in health measurement 
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[20]. The wide range of scale evaluations now associ-
ated with this approach provides relatively crude, but 
broadly useful examinations of the measurement per-
formance of PRO instruments. However, there are 
some significant drawbacks to the approach. In brief, 
there are four main limitations of CTT. First, the 
measures generated are ordinal rather than interval 
(invariance is not hypothesized or experimentally 
tested) [26]. Second, scores for persons and samples 
are scale dependent, as they lack a stochastic frame of 
reference, resulting in item parameters that must be 
regarded as fixed [27]. Third, scale properties, such as 
reliability and validity, are sample dependent. As 
such, the marginal probabilities of measures (ie the 
probability distribution of scale scores) vary across 
population subgroups, as these subgroups may vary in 
the rate of the construct being measured [28]. Fourth, 
the data support group-level inferences but are not 
suitable for individual patient measurement [29]. 
 
1.2.2 Rasch Measurement Theory 
Georg Rasch, a Danish mathematician, was princi-
pally concerned with the measurement of individuals 
rather than distribution of levels of a trait in a popula-
tion. He argued that the core requirement of social 
measurement should be the same as that in physical 
measurement (ie ‘invariant comparison’). With this in 
mind, he developed the simple logistic model (now 
known as the Rasch model). Through applications in 
education and psychology, he was able to demonstrate 
that his approach met the stringent criteria for meas-
urement used in the physical sciences[30]. The for-
mula for his model for scales including dichotomous 
items is: 
 ܲݎሼݔ௡௜ȁߚ௡ǡ ߜ௜ሽ ൌ ݁௫೙೔ሺఉ೙ିఋ೔ሻͳ ൅ ݁ሺఉ೙ିఋ೔ሻ 
(2) 
 
where ݔ௡௜ א ሾͲǡͳሿǢ ߚ௡ and ߜ௜are the measurements 
of person n and item i, respectively, upon the same 
latent trait, and e is the natural logarithm constant 
(2.718).  
Out of Rasch Measurement Theory are born Rasch 
measurement methods (RMMs), which use the Rasch 
model to evaluate the legitimacy of summing items to 
generate measurements, and their reliability and valid-
ity. The model articulates the set of requirements that 
must be met for rating scale data to generate internally 
valid, equal-interval measurements that are stable 
(invariant) across items and people [26]. The central 
tenet to RMMs is that they examine the extent to 
which observed data (patients’ actual responses to 
scale items) accord with (“fit”) predictions of those 
responses from a mathematical (Rasch) model. Thus, 
the difference between what should happen (expected) 
and what does happen (observed) indicates the extent 
to which measurement is achieved.  
Statistical and graphical tests are used to evaluate 
the correspondence of data with the model. Certain 
tests are global, while others focus on specific obser-
vations, items or persons. There are seven key meas-
urement properties that should be considered: thresh-
olds for item response options; item fit statistics; item 
locations; differential item functioning (DIF); correla-
tions between standardised residuals; person separa-
tion index (PSI), individual person change statistics. 
We describe these in more detail elsewhere [25]. 
Direct comparisons of CTT and Rasch psychomet-
ric methods in the health measurement literature are 
sparse, and at best superficial [31, 32]. In part, this 
may be due to the fact that the two approaches cannot 
be compared easily, as they use different methods, 
produce different information, and apply different 
criteria for success and failure. 
However, importantly RMMs address each of the 
four limitations of CTT described above. First, the 
approach offers the ability to construct linear meas-
urements from ordinal-level data, thereby addressing a 
major concern of using
 PRO instruments as outcome 
measures [33, 34]. Second, Rasch measurement meth-
ods provide item estimates that are free from the sam-
ple distribution and person estimates that are free from 
the scale distribution, thus allowing for greater flexi-
bility in situations where different samples or test 
forms are used [35]. Third, the methods allow for the 
use of subsets of items from each scale rather than all 
items from the scale, without compromising the com-
parability of measures made using different sets of 
items. This is the foundation for item banking and 
computerised adaptive testing [36]. Fourth, RMMs 
enable estimates suitable for individual person analy-
ses rather than only for group comparison studies.[37, 
38] 
 
1.2.3 Item Response Theory 
Item Response Theory (IRT) is another body of 
psychometric methods that provides a foundation for 
statistical estimation of parameters that represent the 
locations of persons and items on a latent continuum 
[39]. In particular, IRT scale evaluations are used to 
ascertain the degree to which a given model and pa-
rameter estimates can account for the structure of and 
statistical patterns within a response dataset [13, 39]. 
There are three main models under the general 
banner of IRT. The one parameter (1P) model is es-
sentially identical in structure to the Rasch model 
(Equation 2). Mathematical models relating the prob-
ability of a response to an item, to the person’s loca-
tion, the item’s difficulty and the item’s discrimination 
are known as two parameter (2P) models [40]. The 
addition of a third parameter (a person guessing pa-
rameter [41]) to the basic 2P model results in the 3P 
model [42]. Thus, the basic 2P model for rating scales 
including dichotomously scored items is: 
 ܲݎሼݔ௡௜ȁߚ௡ǡ ߜ௜ ǡ ߙ௜ሽ ൌ ݁௫೙೔ሾఈ೔ሺఉ೙ିఋ೔ሻሿͳ ൅ ݁ሾఈ೔ሺఉ೙ିఋ೔ሻሿ 
(3) 
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which is equivalent to Equation (2), with the addition 
of ߙ௜, which represents the slope of item i (discrimina-
tion). Thus, the basic 3P model is: 
 
 ܲݎሼݔ௡௜ȁߚ௡ǡ ߜ௜ ǡ ߙ௜ ǡ ܿ௜ሽ ൌ ܿ௜ ൅ ሺͳ ൅ ܿ௜ሻ ൅ ݁௫೙೔ሾఈ೔ሺఉ೙ିఋ೔ሻሿͳ ൅ ݁ሾఈ೔ሺఉ೙ିఋ೔ሻሿ 
(4) 
 
In this instance, the additional ܿ௜ represents a con-
stant describing the lower asymptote due to guessing 
for item i. 
The general approach in IRT focuses on mathe-
matical models that explain the observed data. Essen-
tially, models are postulated and examined relative to 
data. When the observed data are not adequately ex-
plained by the mathematical model, that is when the 
data do not fit the chosen model closely enough, an-
other model is tried. Thus, the justification for model 
selection is empirical evidence of its suitability [22]. 
The choice of one model over another hinges on 
whether it accounts better for the data [43]. The data 
are considered given in the sense of being validated on 
the basis of item content, expert opinion or other proc-
esses external to the data. Finally, the four shortcom-
ings of CTT, described above, are overcome by IRT 
only haphazardly and indirectly, depending on 
whether the data in hand are found to fit a 1P model 
that, importantly, has not been conceived from the 
standpoint of specifying the requirements for objective 
inference. 
 
1.2.4 Justification for model choice 
As outlined above, modern psychometric methods, 
such as RMMs, have substantial advantages over CTT 
for developing new PRO instruments. However, given 
the apparent similarity between Rasch measurement 
theory and IRT, does it matter which approach is 
used? Rasch measurement theory and IRT are mathe-
matically similar, so they are often considered as 
members of the same family of statistical techniques 
[13, 44]. This is inaccurate because advocates of 
Rasch measurement theory and IRT have different 
research agendas [13, 44, 45]. 
The distinction between Rasch measurement the-
ory and IRT is subtle but important. IRT models are 
statistical models used to explain data, and as such the 
aim of an IRT analysis is to find the statistical model 
that best explains the observed data [13, 44]. When 
the observed data do not fit the chosen IRT model we 
seek another model to better explain the data. In con-
trast, Rasch measurement theory provides a mathe-
matical model for guiding the construction of stable 
linear measures from rating scale (e.g. PRO instru-
ment) data [30]. Therefore, the aim of RMMs are to 
determine the extent to which observed rating scale 
data satisfy the measurement model. When the data do 
not fit the model, we examine the data carefully to try 
and explain the misfit, but ultimately we choose data 
that satisfies the model’s requirements. It is the central 
tenet of the Rasch Model that distinguishes it from 
IRT models. Specifically, its defining property is its 
mathematical embodiment of the principle of invariant 
comparison. These central tenets distinguish the Rasch 
measurement theory diagnostic paradigm from the 
IRT modelling paradigm [13]. 
Therefore, in developing the new PRO instrument 
for cosmetic and reconstructive breast surgery, we 
selected Rasch measurement methods (RMMs). In 
particular we used the Rasch model for ordered re-
sponse categories, which was developed for scales or 
tests containing polyto smous item  [15, 46]: Prሼܺ௡௜ ൌ ݔሽ ൌ ሾ݁ݔ݌ሺݔሺߚ௡ െ ߜ௜ሻ െ σ ߬௞௜௫௞ୀଵ ሻሿσ ሾ݁ݔ݌ሺݔሺߚ௡ െ ߜ௜ሻ െ σ ߬௞௜௫௞ୀଵ ሻሿ௠೔௫ୀ଴  
(5) 
 
Where ݔ א ሾͲǡͳǡʹǡ ǥ ǡ݉௜ሿ is the integer response 
variable for person n with the ability ߚ௡ responding to 
item i with the difficulty ߜ௜ an  d
߬ଵ௜ ᇱ߬ଶ௜ǡǥǡ ߬௠௜ ᇱ෍߬௫௜  ൌ Ͳ௠଴  
 
௫ୀ
are thresholds between ݉௜ +1 ordered categories 
where ݉௜ is the maximum score of item i, ߬଴ ؠ Ͳ [ 46]. 
This implies a single dimension with values ߚ, ߜ and ߬ 
located additively on the same scale. Thus, the set of 
positive integers x can contain person’s response to 
summated rating scales. For example, in the new PRO 
instrument described in this paper, the satisfaction 
related items include response options containing the 
integers ‘1’, ‘2’, ‘3’, and ‘4’ which represent the se-
mantic categories ‘Very dissatisfied’, ‘Somewhat 
dissatisfied’, ‘Somewhat satisfied’, and ‘Very satis-
fied’.  
Importantly, the equation in the bottom half of the 
Equation 5 is the ‘normalising factor’, which specifies 
the probabilities of exceeding all thresholds for all 
categories preceding k, so that the probability of per-
son n scoring in category k depends upon all the loca-
tions of all the thresholds. This is important as it en-
sures that responses to items are constrained to a 
Guttman pattern, whose success is reflected by or-
dered thresholds. Thus, correctly ordered thresholds 
become an essential element of the validity of items 
[46]; an evaluation supported by readily available 
software [47] and theory [48, 49]. 
 
1.3. Applicable for research and clinical set-
tings 
RMMs for testing and evaluating PRO instruments 
are becoming increasingly used in health measurement 
research [2]. However, for new PRO instruments to be 
appropriately used and widely accepted in different 
clinical scenarios, clinicians require well targeted, 
reliable, and valid instruments that can also be easily 
scored. To achieve this requires both a psychometri-
cally robust PRO instrument and a method of auto-
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matically scoring its data, based on items that are 
appropriately calibrated within a specifically defined, 
clinically meaningful, frame of reference. This is an 
area which has received less attention in the health 
arena [20].  
Therefore, the final step in the development proc-
ess was to produce a standalone executable software 
application to allow data entry, automatic scoring, and 
export based on the most applicable scoring algo-
rithms. We selected the item estimates and calibration 
algorithms housed in the RUMM 2030 software pro-
gram [47]. This is because these algorithms are di-
rectly referable to work of George Rasch [30] and 
David Andrich [15, 38, 46, 48, 49]. 
 
2. METHODS 
The key steps involved in developing the new PRO 
instrument included: development of a conceptual 
framework; item generation; scale formation; and 
psychometric evaluation. In addition, as described 
above, we aimed to build, from the ground up, clinical 
hypotheses for each subscale that could be used to 
postulate a construct theory for each, and then test 
each scale using RMMs. Local institutional ethics 
review board approval was obtained for participating 
centres. 
 
2.1. Conceptual Framework Formation 
To develop a conceptual framework of HR-QL and 
patient satisfaction in breast surgery, we conducted 
semi-structured interviews with breast reconstruction, 
augmentation, and reduction patients [11]. The inter-
views were used to collect rich, detailed data about the 
personal experiences of breast surgery patients. Inter-
views took place in Vancouver (Canada) between 
October and December of 2004. A maximum variation 
sample was chosen to ensure that a broad spectrum of 
age, ethnicity, and surgery types were represented. 
Patient interviews were tape recorded, transcribed, and 
analysed. 
 
2.2. Item Generation, Preliminary Scale Forma-
tion, and Pretesting 
Item generation involved developing an exhaustive list 
of potential items for each domain within our concep-
tual framework. As specific issues varied in impor-
tance by surgical group, separate modules were devel-
oped for breast augmentation, reduction, and recon-
struction patients. Items for each module were devel-
oped using information generated only from inter-
views with patients who had undergone that particular 
type of breast surgery. We also examined existing 
published measures of HR-QL and patient satisfaction 
in breast surgery patients and added items not dis-
cussed by our interviewees. Finally, we had plastic 
surgeons, oncologist breast surgeons, nurses, and 
psychologists working at the University of British 
Columbia (Vancouver), Memorial Sloan-Kettering 
Cancer Center (New York), and University College 
London (London) nominate items that were missing 
from their perspective. 
Our conceptual framework and draft subscales 
were then presented for feedback to two separate fo-
cus groups that included women from the initial quali-
tative interviews and new participants. These sessions 
were used to examine the degree to which our concep-
tual framework resonated with them and covered all 
relevant issues. In addition, experts at four academic 
medical centres in the United States and Canada were 
asked to review the framework and subscales. This led 
to finalizing draft versions of the subscales. Using 
cognitive debriefing techniques, we asked women to 
review these draft versions to determine their under-
standing of each item, to point out any unclear or 
ambiguous items, and to comment on the response 
options and recall periods. Finally, readability of the 
draft subscales was assessed to ensure that all content 
was targeted to a sixth-grade reading level, and revi-
sions were made as necessary [50]. 
 
2.3. Preliminary Field-Testing, Scale Construc-
tion, and Psychometric Evaluation Postal Survey 
Field-test versions of the three procedure-specific 
PRO instruments were mailed to breast surgery pa-
tients recruited from five centres in the United States 
and Canada (n=2715). Eligible participants included 
preoperative and postoperative patients who were able 
to read English and were aged 18 or older. To ensure a 
high response rate, we used personalised letters, stan-
dardised instructions, and up to two reminders as 
necessary [51, 52]. 
 
2.4. Further Validation Field-Testing, Psychomet-
ric Evaluation Postal Survey 
Field-test versions of the three procedure-specific 
PRO instruments were mailed to breast surgery pa-
tients recruited from three centres in the United States 
and Canada (n=1244). Administration methods were 
the same as 2.3. 
 
2.5. Psychometric Analysis  
Essentially, RMMs are used to examine the extent 
to which the observed scale data ‘fit’ with predictions 
of those ratings from the Rasch model (which defines 
how a set of items should perform to generate reliable 
and valid measurements) [30]. Effectively, the differ-
ence between expected (as predicted by the model) 
and observed scores indicates the degree to which 
valid measurement is achieved [25, 38, 53]. In this 
project we examined four key tests for reliable and 
valid measurement using RUMM2030 software (fit, 
targeting, dependency, reliability) [47]. 
Fit. The items of each of the new PRO instru-
ment’s subscales must work together (fit) as a con-
formable set both clinically and statistically. Other-
wise, it is inappropriate to sum item responses to reach 
a total score and consider the total score as a measure 
of each target construct. When items do not work 
together (misfit) in this way, the validity of a subscale 
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is questioned. In brief, evidence for item fit was based 
on four different indicators. These included: ordering 
of item response options (ordering of item thresholds 
[54]), two statistical indicators (fit residual; chi 
square), and one graphical indicator (item characteris-
tic curve; ICC[35]). 
Targeting. Scale-to-sample targeting concerns the 
match between the range of the target construct meas-
ured by each of the subscales and the range of target 
construct in the sample of women in each dataset. In 
brief, this was achieved by an examination of the 
spread of person and item locations in these two rela-
tive distributions. This analysis informs us as to how 
suitable the sample is for evaluating the subscales of 
the new PRO instrument and how suitable the sub-
scales are for measuring their respective samples. 
Better targeting equates to a better ability to interpret 
the psychometric data with confidence [35]. 
Dependency. The responses to any of the items in 
each of the subscales should not directly influence the 
response to any another in the same subscale [55]. If 
this happens, measurement estimates may be biased 
and reliability may be artificially elevated. RMMs 
determine this effect by examining residual correla-
tions. 
Reliability. This was assessed using the Person 
Separation Index (PSI) [48], which is comparable to 
Cronbach’s alpha (Į) [56]. As such, both indices are 
estimates of the proportion of the variance of the dis-
tribution of person estimates. However, a key differ-
ence between the PSI and Į is that when there is mis-
targeting between item and person locations, so that 
there is a skewed distribution with extreme raw 
scores, Į remains more constant than the PSI. This is 
because Į is based on raw scores while the PSI in-
volves a non-linear transformation of these raw scores. 
The error variance for persons increases as the scores 
become more extreme, so with scores close to the 
extreme, the error variance increases in the PSI while 
this is not taken into account in Į [48].  
 
2.6. Final Cognitive Debriefing Interviews 
After the completion of the field test, final mod-
ules and subscales were mailed to a small sample of 
patients in each of the three procedure groups. These 
patients participated in cognitive debriefing interviews 
by phone and were asked to discuss their understand-
ing of the items and to identify unclear or ambiguous 
items. Acceptability and completion time were also 
examined. 
 
2.7. Software development 
Following finalising the items (and item re-
sponses) for each subscale in each module, further 
item analyses based on the RUMM paradigm were 
conducted to provide a precise set of item calibrations 
to base the construction of patient measures. As such, 
the item calibrations, in conjunction with the item 
statements, define what “more than” or “less than” 
means in terms of the patient location on the final 
calibrated scale, a fundamental criterion behind all 
scientific measurement. These item calibrations in 
conjunction with the RUMM2030 algorithms were 
used to develop the software engine for a new scoring 
program together with a Graphical User Interface to 
allow for ease of use. Together, these produce an 
application that would be able to provide automated 
clinically interpretable scores, based on fixed cali-
brated item locations. 
 
3. RESULTS 
3.1. Conceptual Framework Formation 
Forty-eight breast surgery patients were inter-
viewed, generating a total of 2749 statements about 
HR-QL and patient satisfaction. Based on patient 
interviews, research literature, and expert opinion, the 
following six key themes formed our conceptual 
framework of HR-QL and patient satisfaction in breast 
surgery (Fig. 1): 
 
 
 
Fig. 1. BREAST-Q © conceptual framework 
 
3.2. Item Generation, Preliminary Scale Forma-
tion, and Pretesting 
The process of item generation led to three initial 
pools of items from augmentation (n = 145 items), 
reconstruction (n = 240 items), and reduction (n = 163 
items) patients. Items within each pool were grouped 
into domains based on their conceptual meaning to 
represent coherent clinically meaningful constructs. 
These formed the domains of the conceptual frame-
work for each type of surgery. The research team then 
iteratively and interactively examined each of the item 
lists in each of the domains to identify and retain those 
potential items that best represented aspects of the 
continuum of impact for each domain and to form the 
best potential subscale. Preoperative items were re-
peated in the postoperative subscales along with addi-
tional “postoperative only” questions (e.g., items re-
lated to scarring). 
This process resulted in the core domains of the 
conceptual framework and led to the development of 
preliminary subscales for each of the three modules. 
Four additional preliminary subscales to address is-
sues specific to single procedure groups were also 
created (i.e., Reconstruction module: satisfaction with 
abdominal appearance, physical well-being trunk and 
abdomen, and satisfaction with nipple-areola recon-
struction; Reduction module: satisfaction with nipple-
areola).  
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3.2.3 Psychometric Evaluation Instructions for completing each subscale asked 
patients to comment on their HR-QL or satisfaction 
aspects of during the previous 2 weeks. This recall 
period was determined to be acceptable to patients, 
clinically relevant, and best conveyed as sense of 
“current status” for the patient groups. An exception 
to this rule was made for the sexual well-being sub-
scale as “2 weeks” was not felt to be an acceptable 
interval given that sexuality in the weeks preceding 
surgery was not necessarily indicative of a patient’s 
usual status. Cognitive debriefing interviews included 
12 reduction, 11 augmentation, and 23 reconstruction 
changes in wording. 
Rasch analysis supported the summing of items to 
form a total score for each subscale of each of the 
modules. Scale reliability was supported by satisfac-
tory Person separation indices (>0.76), and validity 
was supported by three findings. First, item response 
option thresholds were ordered correctly for all items, 
indicating that the proposed response options were 
working well. Second, the item locations in each sub-
scale were spread out (range, 0.9 to 4.4), indicating 
that each subscale defined a continuum. Third, the 
vast majority of residual correlations for each subscale 
were less than 0.30, supporting local independence 
among items (data available from authors). Fit to the 
Rasch model was good, as all of the retained items in 
each subscale had acceptable fit residuals and the 
majority of chi-square values were non-significant.  
 
3.2. Field Testing, Scale Formation, and Psycho-
metric Evaluation Postal Survey 
3.2.1 Sample 
Questionnaire booklets were sent to 2715 women, 
and 1950 were returned completed (response rate, 72 
percent; Table 1). 
The minority of items that had fit statistics slightly 
larger than expected were examined and retained on 
the basis of appraisals of overall psychometric per-
formance and clinical relevance. Further details about 
item calibrations, standard errors, fit residuals, and 
chi-square statistics are available from the authors.  
 
Table 1: Patient Characteristics: Field Testing 
 
 
To illustrate, we provide an example of one of the 
subscales below. As such, Fig. 2 shows the subscale 
structure and layout of the BREAST-Q © Reconstruc-
tion Module: Satisfaction with Breasts subscale. This 
subscale address issues surrounding patient satisfac-
tion relating to their perceptions of the result of recon-
struction surgery. This is almost always following 
unilateral or bilateral mastectomy following a diagno-
sis of breast cancer. 
3.2.2 Scale Formation 
In each subscale, items with the best psychometric 
properties, while appropriately representing each of 
the target constructs, were retained in the reconstruc-
tion, reduction, and augmentation modules. We named 
this new PRO instrument the BREAST-Q ©. Further 
information is available from the authors.  
 
Fig. 2. BREAST-Q © Reconstruction Module: Satisfaction 
with Breasts subscale.  
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The item content and ordering of this subscale reflects 
the hypothesised clinical hierarchy of the construct. 
The items are ordered from the items which reflect 
lowest through to highest patient satisfaction. Thus, a 
patient endorsing degrees of satisfaction with the first 
item “How you look in mirror clothed”, but dissatis-
faction with all other items indicates low satisfaction 
for this woman. Alternatively, a patient scoring “Very 
satisfied” to the last question (“How you look in mir-
ror unclothed”) indicates the highest level of satisfac-
tion. This hierarchy is supported in the RMMs analy-
ses, and is demonstrated in the item threshold map and 
correctly ordered thresholds (Spearman’s Rho=0.97 
between hypothesised and Rasch measurement de-
rived subscale hierarchy; Fig. 3). This is further elabo-
rated upon in Fig. 4 which shows category probability 
curves (CPCs) from item i) ‘How equal in size your 
breasts are to each other’.   
Item fit to the Rasch model was good overall. 
Three items just marginally fell outside (<0.4) of the 
fit residual guidelines of -2.5 to +2.5, but all three 
items demonstrated good psychometric properties in 
all other tests. Fig. 5 shows an example of one of the 
graphics associated with tests of fit for item n) ‘How 
closely are your breasts matched to each other’. 
The final illustration is presented in Fig. 6, which 
shows the targeting of the subscale to the sample. In 
this figure, the upper histogram represents the sample 
distribution of total BREAST-Q © Reconstruction 
Module: Satisfaction with Breasts subscale person 
measures. The lower histogram striped blocks repre-
sent the sample distribution of the item thresholds of 
the 15-items of the same subscale. The line shows the 
information function. The graph shows that the distri-
butions of item thresholds and person measures are 
well matched. There is also some potential to extend 
the range of measurement by adding items to the ex-
tremes of the subscale range. The peak of the informa-
tion plot is around 0.9 logits of the continuum which 
indicates the scale’s best point of measurement. The 
PSI=0.94. 
 
 
Fig. 3: Threshold map for all items in the BREAST-Q © 
Reconstruction Module: Satisfaction with Breasts subscale. 
The x-axis represents the construct (satisfaction with breasts 
after reconstruction surgery), with patient satisfaction in-
creasing to the right. The y-axis shows each of the items 
response category ‘Very Unsatisfied’ labelled 0; Response 
category ‘Somewhat dissatisfied’ labelled 1 (black block); 
Response category ‘Somewhat satisfied’ labelled 2; Re-
sponse category ‘Very satisfied’ labelled 3 
 
 
 
 
Fig. 4: Category probability curves for item i) ‘How equal in 
size your breasts are to each other’. The x-axis represents 
the construct (satisfaction with breasts after reconstruction 
surgery), with patient satisfaction increasing to the right. 
The y-axis shows the probability of endorsing the response 
categories, reading left to right: 0 (first curve) ‘Very Unsat-
isfied’, 1 (second curve) ‘Somewhat dissatisfied’, 2 (third 
curve) ‘Somewhat satisfied’, and 3 (fourth curve) ‘Very 
satisfied’. Key: Locn = location; FitRes = Fit residual; Pr = 
probability 
 
 
Fig. 5: Item characteristic curve for n) ‘How closely are you 
breast matched to each other’. The x-axis represents the 
construct (satisfaction with breasts after reconstruction 
surgery), with patient satisfaction increasing to the right. 
The y-axis shows the expected value as predicted by the 
Rasch model. The black dots, which represent class inter-
vals, are very close to the line indicating a close association 
between observed and expected scores. Key: Locn = loca-
tion; FitRes = Fit residual; Pr = probability 
 
 
Fig. 5: Person-Item thresholds Distribution. The x-axis 
represents the construct (satisfaction with breasts after re-
construction surgery), with patient satisfaction increasing to 
the right. The y-axis shows the frequency of person measure 
locations (top histogram) and item locations (bottom histo-
gram). 
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3.3. Further Validation Field Testing, and Psy-
chometric Evaluation Postal Survey 
3.5. Software development 
The Q-Score © application (Fig. 7.) was developed 
to transform each BREAST-Q © subscale score in 
each module. It provides the ability to read patient 
subscale response data into the program, score the set 
of responses to each subscale attempted, and write the 
complete set of transformed scores for all subscales 
attempted to an electronic file. Once the set of re-
sponses are accepted, the program immediately scores 
these data and estimates a Rasch-based person meas-
ure, ranging from 0 to 100. This measure is based on 
the calibration of each set of items in each subscale. 
All item response data, scoring and measures can then 
be exported into text file for further analyses. 
3.3.1 Sample 
Questionnaire booklets were sent to 1244 women, 
and 817 were returned completed (corrected response 
rate 66%; Table 2).  
 
3.3.1 Psychometric Evaluation  
Rasch analysis supported the summing of items to 
form a total score for all subscales of each module. 
Validity was supported by three findings. First, item 
response option thresholds were ordered correctly for 
all items in all subscales, indicating that the proposed 
response options worked well. Second, the item loca-
tions in each subscale were spread out (range of logit 
span 0.7-6.6) indicating that each subscale defined a 
continuum. Third, fit to the Rasch model was good as 
the vast majority of items in all subscales of each 
module had acceptable fit residuals, and Chi-square 
values that were non-significant. The minority of 
items falling outside recommended criteria had fit 
statistics marginally larger than expected. Scale reli-
ability was supported by satisfactory Person Separa-
tion Indices (>/= 0.73) with the exception of Physical 
Wellbeing. Further information is available from the 
authors.  
 
 
Fig. 7. Q-Score user interface.  
 Table 2: Patient Characteristic: Further Validation Field 
Testing (post-surgery) 4. DISCUSSION 
Patients provide a unique and vital perspective on the 
success of breast surgery procedures. To fully capture 
and quantify their perceptions, appropriately con-
structed and validated PRO instruments are needed. 
The new instrument (the BREAST-Q©) consists of 
three procedure-specific modules (augmentation, 
reduction, and reconstruction) with independent sub-
scales that examine those issues most important to 
women who have undergone each procedure. By 
closely targeting the subscales and items to the spe-
cific surgical group, each module has the potential to 
be more sensitive to patient perceptions and respon-
sive to change following surgery. 
 
 
 
4.1. The “Patient Voice” 
Overall, patient input proved to be the most impor-
tant element of the development process. In develop-
ing the conceptual framework for the BREAST-Q, we 
sought to create a model that would reflect the entirety 
of the patient experience. Patients expressed both a 
sense of “appraisal” of the results of surgery (e.g., 
satisfaction or dissatisfaction), as well as an awareness 
of the impact of the procedure on their health-related 
quality of life. Our conceptual framework thus con-
sists of both HR-QL subscales (psychosocial, physi-
cal, and sexual well-being) and satisfaction subscales 
(satisfaction with breasts, satisfaction with overall 
outcome, and satisfaction with the process of care).  
3.4. Final Cognitive Debriefing Interviews 
Thirty patients (10 from each procedure group) re-
viewed the final modules and subscales. They reported 
completion time to be 10 to 14 minutes for the recon-
struction, 10 to 12 minutes for reduction, and 8 to 10 
minutes for augmentation modules. They found the 
subscales to be acceptable, comprehensive, and clear. 
Patients in our interviews and focus groups repeat-
edly reflected on their relationship with the surgeon, 
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4.3. A practical solution to scoring the information that they received, and the care pro-
vided by the office staff. Process of care is measured 
by separate subscales that examine satisfaction with 
preoperative information and the care provided by the 
plastic surgeon, the office staff, and other members of 
the medical team. These process measures may ulti-
mately prove to be useful for quality improvement 
efforts. As an example, a plastic surgeon may use 
these subscales to obtain useful metrics for individual 
practice improvement.  
Traditionally, PRO instrument users have been re-
quired to handle data manually, producing total scores 
via scoring syntax in statistical software packages, or 
other similar tools. These complications can be a bar-
rier to the use of PRO instruments, especially for cli-
nicians in busy practices or clinical researchers who 
are using these instruments as part of a larger study. 
Overcoming these barriers is especially relevant in the 
context of the more complex algorithms and software 
associated with RMMs. The new Q-Score © program 
offers a ready solution to this issue. It provides an 
easy, automatic, convenient and tangible 0-100 score 
transformation that maintains a common frame of 
reference and metric comparability across different 
clinical samples; linearised (not ordinal) measures 
satisfying statistical assumptions of unit additivity; 
and it supports both group and individual-patient level 
comparisons. 
 
4.1. Benefits of Rasch Measurement Methods 
The use of RMMs to develop and test the subs-
cales of the BREAST-Q © means that we have a good 
understanding of the empirical item order across each 
subscale. Thus, we know which items are associated 
with each and every possible subscale score. For ex-
ample, using the BREAST-Q © Reconstruction Satis-
faction with Breasts subscale (described above), a 
recent multicenter, cross-sectional study of 672 post 
mastectomy women, conducted by our group, found 
that women's satisfaction with their breasts was signif-
icantly greater among those who received silicone 
implants compared with those who received saline 
implants [
 
4.4. Next steps 
Based on the development process and the prelim-
inary validation data, we would argue that the 
BREAST-Q © is a promising PRO instrument that 
provides a scientifically rigorous and clinically valid 
means to examine the impact of breast surgery from 
the patient perspective. As increasing numbers of 
researchers and surgeons incorporate the BREAST-Q 
© into their studies and surgical practices, we envision 
a rapidly expanding knowledge base that will inform 
further clinical interpretation of BREAST-Q © data. 
Thus, as BREAST-Q © data grows from different 
clinical scenarios, the interpretation and, therefore, the 
clinical meaning, of its subscale scores will become 
increasingly clarified. As we seek to optimally man-
age surgical patients in an increasingly cost-restricted 
environment, the BREAST-Q © can be expected to 
provide meaningful data to guide determination of 
comparative effectiveness and patient advocacy. 
57]. We can add the words used in the items 
in the range of the subscale scores for the silicone 
group (mean score 64) and the saline group (mean 
score 57; Fig. 8).  
 
We would recommend that further work is carried 
out on the BREAST-Q ©. First, our response rate 
(66%) in the validation filed test was lower than 
achieved in our first field-test (72%) [12]. This differ-
ence is probably due to the increased respondent bur-
den of the substantially longer questionnaire booklet 
used in the validation study. And, in fact, this sugges-
tion is supported by other studies. For example, the 
recent UK National Mastectomy and Breast Recon-
struction Outcomes Audit [
Fig. 8 Illustration of comparison of saline and silicone group 
means scores on the “ruler” of BREAST-Q © Reconstruc-
tion Satisfaction with Breasts subscale 
 
These translate into the following: women in the 
silicone group scoring higher up the subscale and, 
therefore, typically satisfied with their look and feel of 
their reconstructed breasts, whereas women in the 
saline group category are towards the middle of the 
subscale and are satisfied with size and look of their 
breasts, but not how well they match or feel natural. 
The ability to provide qualitative statements to each 
group for each subscale score begins to make concrete 
the meaning of subscale scores and thus provides a 
clear base for the clinical interpretation of the 
BREAST-Q © [16]. 
58] reported an 84% re-
sponse rate (n=6882) for the BREAST-Q ©. But while 
it is unlikely that the lower response rate achieved in 
our study reflects problems with patient acceptability 
of the BREAST-Q ©, which in fact exceeds 60% (the 
average response rate [59] and proposed minimum 
[60] for clinical research), further work is required to 
establish specific response rates.  
Second, further psychometric examination remains 
to be done, including: comparisons with objective 
clinical data; comparisons of test-retest administration 
techniques (combined versus individual mailings); 
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group- and individual-patient level clinical change 
(responsiveness); and formal cross-cultural validations 
of translated versions of the BREAST-Q ©.  
Finally, developing the BREAST-Q © using 
RMMs means that we can legitimately continue to 
refine and improve the measurement performance of 
its subscales, while the current version is being used 
[13]. In addition, the scores generated from future 
versions of the BREAST-Q© will be directly compa-
rable to the present version to retain continuity. Thus, 
further work will include further development of the 
construct theories underpinning each subscale, exami-
nation of differential item functioning, residual corre-
lations, and the potential of including new or modified 
items to improve upon and/or expand the measure-
ment continuum of each subscale, if and where neces-
sary. 
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